|
rdfs:label
|
"Anakinra"@de
"Anakinra"@id
"Anakinra"@it
"Anakinra"@nb
"Anakinra"@sh
"Anakinra"@sl
"Anakinra"@sr
"Anakinra"@vi
"anacinra"@pt
"anakinra"@ca
"anakinra"@en
"anakinra"@es
"anakinra"@fr
"anakinra"@nl
"anakinra"@pl
"Анакінра"@uk
"анакинра"@ru
"آناكينرا"@ar
"آناکینرا"@azb
"آناکینرا"@fa
"ଆନାକିନରା"@or
"అనాకిన్రా"@te
"アナキンラ"@ja
"阿那白滯素"@zh
|
|
skos:altLabel
|
"143090-92-0"@fr
"Antril"@en
"C759H1186N208O232S10"@fr
"ICIL-1RA"@en
"IL-1RN"@en
"IL-1ra"@en
"IL1 inhibitor"@en
"IRAP"@en
"Interleukin-1-Rezeptorantagonist"@de
"Kineret"@de
"interleukin-1 receptor antagonist protein precursor"@en
"Кинерет"@ru
|
|
schema:description
|
"cheemesch Verbindung"@lb
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"kemia kombinaĵo"@eo
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"pharmaceutical drug, interleukin 1 receptor antagonist"@en
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"лекарственное средство; искусственно синтезируемый антагонист рецептора интерлейкина 1"@ru
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"ଏହା ରିଉମାଟଏଡ ଆର୍ଥ୍ରାଇଟିସ୍, କ୍ରିଓପାଇରିନ-ଜଡିତ ପିରିଓଡିକ ସିଣ୍ଡ୍ରୋମ, ପାରିବାରିକ ଭୂମଧ୍ୟସାଗରୀୟ ଜ୍ୱର ଏବଂ ସ୍ଟିଲସ ରୋଗର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ଏକ ଔଷଧ ।"@or
|
|
schema:dateModified
|
"2026-11-04T08:54:27+00:00"^^xsd:dateTime
|
|
schema:version
|
2564626203
|
|
wikibase:identifiers
|
24
|
|
wikibase:sitelinks
|
22
|
|
wikibase:statements
|
45
|
|
p:P10245
|
wd:statement/Q415411-6b30ae2f-4026-cde4-1001-1965ca3dedf9
|
|
p:P10283
|
wd:statement/Q415411-7CBE7723-F34C-489A-BD6B-E4871E38ABF6
|
|
p:P11089
|
wd:statement/Q415411-01F1EFD6-B9FB-4B1E-8489-840D475AE5EB
|
|
p:P11143
|
wd:statement/Q415411-825BFA65-23E5-4E4B-9A59-07842AB95112
|
|
p:P1552
|
wd:statement/Q415411-50C1DE7D-916A-4C2A-80AF-95DD486F5810
|
|
p:P1748
|
wd:statement/Q415411-42F5021B-35AC-44A5-8157-0D0F20A8B767
|
|
p:P2017
|
wd:statement/Q415411-4C35467D-751A-4E3F-83CB-DA2BE29DCAE5
|
|
p:P2067
|
wd:statement/Q415411-4962F7A9-145B-4C31-A1FC-B2F6EBC6E97D
|
|
p:P2115
|
wd:statement/Q415411-C6850F3F-26B0-4DF9-90A0-23481EDBB9C8
|
|
p:P2175
|
wd:statement/Q415411-2A59E238-E2E1-4EB1-8110-D60F9157DCEF
|
|
wd:statement/Q415411-B15C5FB0-CCFD-4A45-8069-0A107AD112C1
|
|
wd:statement/Q415411-F42C1059-5E2C-448D-9467-2228970B8678
|
|
p:P231
|
wd:statement/Q415411-9A030C75-9F38-4D1E-8865-42C6D82E1095
|
|
p:P233
|
wd:statement/Q415411-9DAA692F-7105-426B-BF06-9DE96E5EA88F
|
|
p:P234
|
wd:statement/Q415411-F3961156-6B05-4AD4-B23A-6B69A371E5AC
|
|
p:P235
|
wd:statement/Q415411-69C8D080-D776-431E-9813-2DE1AA41B8FC
|
|
p:P267
|
wd:statement/Q415411-f7a766a8-4306-e467-63c7-9da433645599
|
|
p:P274
|
wd:statement/Q415411-d8e4f91c-4b2b-804d-2bf0-c719b022d976
|
|
p:P279
|
wd:statement/Q415411-34B159F2-304D-46ED-99CA-A7487DEEFCB1
|
|
p:P2868
|
wd:statement/Q415411-9A4B8C0E-7EFC-4C8D-9061-C6B4D45CD69C
|
|
p:P2877
|
wd:statement/Q415411-C360A3BE-D492-45E2-9795-0B0110BA1F9D
|
|
p:P31
|
wd:statement/Q415411-3B81048F-9D0D-46A4-A108-3FF70DE1BD80
|
|
p:P3345
|
wd:statement/Q415411-B223871E-C19A-494B-AB75-4036C94C862D
|
|
p:P3489
|
wd:statement/Q415411-3C3B5251-89CD-484D-BB15-3EB75CBB2C79
|
|
wd:statement/Q415411-926E7C5A-88EC-4201-8549-768B8A5E436C
|
|
p:P366
|
wd:statement/Q415411-CB1D260A-D338-407D-A902-D4D4B0571CE2
|
|
p:P3780
|
wd:statement/Q415411-AEC4B3FD-77BD-4B80-8E48-5BD140F9CAE9
|
|
p:P4235
|
wd:statement/Q415411-A2F3F5CD-6AEB-418D-903C-70281225156D
|
|
p:P4250
|
wd:statement/Q415411-04C5DCAE-1097-4819-8297-8EF3FAF86866
|
|
p:P4527
|
wd:statement/Q415411-6FAD5404-18DB-4913-830B-7CB309C2BFE0
|
|
p:P5076
|
wd:statement/Q415411-C81E7967-2432-47F4-9973-3B5DA6CCEBB8
|
|
p:P527
|
wd:statement/Q415411-B642AF02-05A8-4A23-9C07-397B1DADEB7A
|
|
p:P592
|
wd:statement/Q415411-C414F99B-077D-4F5B-B011-9EBBE0718BE9
|
|
p:P595
|
wd:statement/Q415411-2f10d6c4-40da-0911-cb35-7b9807001f84
|
|
p:P6366
|
wd:statement/Q415411-1BE24F15-F66F-4824-B583-1E3AAA26E556
|
|
p:P646
|
wd:statement/Q415411-455DE059-8E05-4DA8-8639-9AD1EED7192F
|
|
p:P652
|
wd:statement/Q415411-4AB954C4-6830-4182-8ECE-AA38B0A86E3A
|
|
p:P662
|
wd:statement/Q415411-DAD54559-B852-4849-A650-762F175A32A1
|
|
wd:statement/Q415411-e35aa53b-41f5-2ef6-28b0-4c815c130234
|
|
p:P665
|
wd:statement/Q415411-58E7419A-4E5A-44A5-BF8E-6C711CB6916A
|
|
p:P715
|
wd:statement/Q415411-A8FA7F2F-1FC7-4D40-A9BC-CCB997946D94
|
|
p:P769
|
wd:statement/Q415411-AE1D5A07-F1C6-4F25-9879-16E452DA76CB
|
|
p:P7830
|
wd:statement/Q415411-5266E22A-245A-452E-BC57-B9A3FE666950
|
|
p:P8026
|
wd:statement/Q415411-F19CB7CA-ED78-4984-85AC-072D9A1F896E
|
|
p:P8224
|
wd:statement/Q415411-562DEADF-6E33-40DC-B0EC-B4181F808D64
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000148718>
|
|
p:direct-normalized/P4527
|
<http://data.parliament.uk/terms/434862>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201570>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2781228260>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139595263>
|
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90470007>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D02934>
|
|
wdt:P10245
|
"a602001"
|
|
wdt:P10283
|
"C2781228260"
|
|
wdt:P11089
|
"170931737"
|
|
wdt:P11143
|
"Anakinra"
|
|
wdt:P1552
|
biopharmaceutical
|
|
wdt:P1748
|
"C38717"
|
|
wdt:P2017
|
"C=CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OCOC(=O)C(C)(C)C)c3csc(=N)[nH]3)C2SC1"
|
|
wdt:P2067
|
509.103890076^^xsd:decimal
|
|
wdt:P2115
|
"N0000148718"
|
|
wdt:P2175
|
systemic-onset juvenile idiopathic arthritis
|
|
rheumatoid arthritis
|
|
pericarditis
|
|
wdt:P231
|
"143090-92-0"
|
|
wdt:P233
|
"C=CC1=C(C(=O)O)N2C(=O)C(NC(=O)C(=NOCOC(=O)C(C)(C)C)c3csc(=N)[nH]3)C2SC1"
|
|
wdt:P234
|
"InChI=1S/C20H23N5O7S2/c1-5-9-6-33-16-12(15(27)25(16)13(9)17(28)29)23-14(26)11(10-7-34-19(21)22-10)24-32-8-31-18(30)20(2,3)4/h5,7,12,16H,1,6,8H2,2-4H3,(H2,21,22)(H,23,26)(H,28,29)/b24-11-/t12-,16?/m1/s1"
|
|
wdt:P235
|
"HMLGSIZOMSVISS-ONJSNURVSA-N"
|
|
wdt:P267
|
"L04AC03"
|
|
wdt:P274
|
"C₂₀H₂₃N₅O₇S₂"
|
|
wdt:P279
|
7-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
|
wdt:P2868
|
enzyme inhibitor
|
|
wdt:P2877
|
"30295507"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3345
|
"72435"
|
|
wdt:P3489
|
US pregnancy category B
|
|
Australian pregnancy category B1
|
|
wdt:P366
|
medication
|
|
wdt:P3780
|
Kineret
|
|
wdt:P4235
|
"anakinra"
|
|
wdt:P4250
|
0.1^^xsd:decimal
|
|
wdt:P4527
|
"434862"
|
|
wdt:P5076
|
"RD-01-04926"
|
|
wdt:P527
|
carbon
|
|
wdt:P592
|
"CHEMBL1201570"
|
|
wdt:P595
|
"6972"
|
|
wdt:P6366
|
"2781228260"
|
|
wdt:P646
|
"/m/05_c6l"
|
|
wdt:P652
|
"9013DUQ28K"
|
|
wdt:P662
|
"139595263"
|
|
"90470007"
|
|
wdt:P665
|
"D02934"
|
|
wdt:P715
|
"DB00026"
|
|
wdt:P769
|
golimumab
|
|
wdt:P7830
|
"Anakinra"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category C
|
|
wdt:P8224
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Anakinra.png>
|